Manhattan Scients
Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The c… Read more
Manhattan Scients (MHTX) - Total Liabilities
Latest total liabilities as of June 2024: $2.42 Million USD
Based on the latest financial reports, Manhattan Scients (MHTX) has total liabilities worth $2.42 Million USD as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Manhattan Scients - Total Liabilities Trend (1999–2023)
This chart illustrates how Manhattan Scients's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Manhattan Scients Competitors by Total Liabilities
The table below lists competitors of Manhattan Scients ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bee Vectoring Technologies International Inc
PINK:BEVVF
|
USA | $2.23 Million |
|
Finnovate Acquisition Corp. Warrants
NASDAQ:FNVTW
|
USA | $4.14 Million |
|
Cryomass Technologies Inc
OTCQX:CRYM
|
USA | $10.57 Million |
|
NORDIC AMER TANKER
MU:B3O
|
Germany | €335.96 Million |
|
Sayward Capital Corp
V:SAWC-P
|
Canada | CA$0.00 |
Liability Composition Analysis (1999–2023)
This chart breaks down Manhattan Scients's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 32.65 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Manhattan Scients's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Manhattan Scients (1999–2023)
The table below shows the annual total liabilities of Manhattan Scients from 1999 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $2.12 Million | -22.30% |
| 2022-12-31 | $2.73 Million | +12.69% |
| 2021-12-31 | $2.42 Million | +11.27% |
| 2020-12-31 | $2.17 Million | -32.69% |
| 2019-12-31 | $3.23 Million | +14.95% |
| 2018-12-31 | $2.81 Million | +4.66% |
| 2017-12-31 | $2.69 Million | -45.34% |
| 2016-12-31 | $4.91 Million | +14.90% |
| 2015-12-31 | $4.28 Million | -4.26% |
| 2014-12-31 | $4.46 Million | +8.93% |
| 2013-12-31 | $4.10 Million | +54.68% |
| 2012-12-31 | $2.65 Million | +28.14% |
| 2011-12-31 | $2.07 Million | +11.42% |
| 2010-12-31 | $1.86 Million | +6.79% |
| 2009-12-31 | $1.74 Million | -6.61% |
| 2008-12-31 | $1.86 Million | +3.68% |
| 2007-12-31 | $1.79 Million | -39.72% |
| 2006-12-31 | $2.98 Million | +5.16% |
| 2005-12-31 | $2.83 Million | -8.62% |
| 2004-12-31 | $3.10 Million | +29.99% |
| 2003-12-31 | $2.38 Million | +4.61% |
| 2002-12-31 | $2.28 Million | +64.55% |
| 2001-12-31 | $1.39 Million | +69.73% |
| 2000-12-31 | $816.00K | +60.63% |
| 1999-12-31 | $508.00K | -- |